Use of first-generation antihistamines and risk of acute symptomatic crises: an emerging adverse effect in children?
##plugins.themes.bootstrap3.article.main##
Abstract
Acute symptomatic seizures, in any of their forms, represent a common reason for medical consultation in both infants and older adults. However, during the extreme stages of life, early childhood and old age, their occurrence reflects heightened vulnerability, not only due to the immediate clinical implications but also because of the potential risk of long-term neurocognitive consequences. In infancy, particularly within the first two years of life, the brain undergoes a period of rapid development, during which any disruption, even if transient, may result in significant effects. Therefore, any factor that may increase seizure susceptibility warrants careful attention from both clinical medicine and public health perspectives.
Downloads
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.